Literature DB >> 32808353

The airway fungal microbiome in asthma.

Eva-Maria Rick1, Kerry F Woolnough2, Paul J Seear1, Abbie Fairs1, Jack Satchwell1, Matthew Richardson2, William R Monteiro2, Michelle Craner2, Michelle Bourne2, Andrew J Wardlaw1,2, Catherine H Pashley1.   

Abstract

BACKGROUND: Fungal involvement in asthma is associated with severe disease. The full spectrum of fungal species in asthma is not well described and is derived largely from insensitive culture techniques.
OBJECTIVES: To use high-throughput sequencing to describe the airway mycobiota in asthmatics with and without fungal sensitization and healthy controls; to compare samples representing different airway compartments; to determine whether the mycobiota was influenced by the fungal composition of outdoor air; and to compare findings with clinically relevant outcomes.
METHODS: We amplified the internal transcribed spacer region 2 of the nuclear ribosomal operon to identify the fungal species present. Ninety-seven subjects were recruited and provided sputum (83 asthmatics; 14 healthy subjects), with 29 also undergoing a bronchoscopy. A subset of airway samples were compared with matched outdoor air and mouthwash samples.
RESULTS: Two hundred and six taxa at the species level were identified in sputum, most at low relative abundance. Aspergillus fumigatus, Candida albicans and Mycosphaerella tassiana had the highest relative abundances and were the most prevalent species across all subjects. The airway mycobiota consisted of a complex community with high diversity between individuals. Notable shifts in the balance of fungi detected in the lung were associated with asthma status, asthma duration and biomarkers of inflammation. Aspergillus tubingensis, a member of the Aspergillus niger species complex, was most prevalent from bronchoscopic protected brush samples and significantly associated with a low sputum neutrophilia. Cryptococcus pseudolongus, from the Cryptococcus humicola species complex, was more abundant from bronchoscopy samples than sputum, and differentially more abundant in asthma than health. CONCLUSIONS AND CLINICAL RELEVANCE: The airway mycobiota was dominated by a relatively small number of species, but was distinct from the oropharyngeal mycobiota and air samples. Members of the A. niger and C. humicola species complexes may play unexpected roles in the pathogenesis of asthma.
© 2020 The Authors. Clinical & Experimental Allergy published by John Wiley & Sons Ltd.

Entities:  

Keywords:  fungal colonisation; fungal sensitisation; high-throughput sequencing; mycobiome

Year:  2020        PMID: 32808353     DOI: 10.1111/cea.13722

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  9 in total

Review 1.  Clinical Aspergillus Signatures in COPD and Bronchiectasis.

Authors:  Pei Yee Tiew; Kai Xian Thng; Sanjay H Chotirmall
Journal:  J Fungi (Basel)       Date:  2022-05-05

Review 2.  Crossing Kingdoms: How the Mycobiota and Fungal-Bacterial Interactions Impact Host Health and Disease.

Authors:  William Santus; Jason R Devlin; Judith Behnsen
Journal:  Infect Immun       Date:  2021-03-17       Impact factor: 3.441

Review 3.  Aspergillus fumigatus-Host Interactions Mediating Airway Wall Remodelling in Asthma.

Authors:  Sara Namvar; Briony Labram; Jessica Rowley; Sarah Herrick
Journal:  J Fungi (Basel)       Date:  2022-02-06

Review 4.  Impact of Therapeutics on Unified Immunity During Allergic Asthma and Respiratory Infections.

Authors:  Armando S Flores-Torres; Amali E Samarasinghe
Journal:  Front Allergy       Date:  2022-03-25

Review 5.  Recent Advances in Fungal Infections: From Lung Ecology to Therapeutic Strategies With a Focus on Aspergillus spp.

Authors:  Fabio Palmieri; Angela Koutsokera; Eric Bernasconi; Pilar Junier; Christophe von Garnier; Niki Ubags
Journal:  Front Med (Lausanne)       Date:  2022-03-21

6.  Effect of inhaled corticosteroids on microbiome and microbial correlations in asthma over a 9-month period.

Authors:  Chunrong Huang; Yingmeng Ni; Wei Du; Guochao Shi
Journal:  Clin Transl Sci       Date:  2022-05-23       Impact factor: 4.438

Review 7.  New Perspectives in the Diagnosis and Management of Allergic Fungal Airway Disease.

Authors:  Andrew J Wardlaw; Eva-Maria Rick; Leyla Pur Ozyigit; Alys Scadding; Erol A Gaillard; Catherine H Pashley
Journal:  J Asthma Allergy       Date:  2021-05-25

Review 8.  Allergic fungal airways disease (AFAD): an under-recognised asthma endotype.

Authors:  Catherine H Pashley; Andrew J Wardlaw
Journal:  Mycopathologia       Date:  2021-05-27       Impact factor: 2.574

9.  Factors Influencing the Fungal Diversity on Audio-Visual Materials.

Authors:  Tereza Branysova; Martina Kracmarova; Michal Durovic; Katerina Demnerova; Hana Stiborova
Journal:  Microorganisms       Date:  2021-12-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.